Tracy Delong
Nurse Practitioner · Irvine, CANPI 1427772748
Payments from drug & device makers
Across 73 payments — averaging $30.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Lilly USA, LLC$397
- AbbVie$364
- Sanofi$149
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$149
- Halozyme Inc$146
- Johnson & Johnson$141
- plus $888 from 16 others
What the payments were for
- Travel & lodging$40%
- Food & beverage$2,230100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Lilly USA, LLC | 8 | $397 |
| AbbVie | 11 | $364 |
| Sanofi | 1 | $149 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $149 |
| Halozyme Inc | 4 | $146 |
| Johnson & Johnson | 3 | $141 |
| AstraZeneca | 2 | $130 |
| GSK | 5 | $126 |
| Noven Therapeutics, LLC | 6 | $112 |
| Novo Nordisk | 4 | $84 |
| Pfizer | 4 | $65 |
| Antares Pharma, Inc. | 4 | $64 |
| Almatica Pharma LLC | 2 | $51 |
| Phathom Pharmaceuticals, Inc. | 2 | $40 |
| Tris Pharma Inc | 2 | $36 |
| Idorsia Pharmaceuticals US Inc | 2 | $33 |
| Krystal Biotech Inc | 1 | $32 |
| Baxter Healthcare | 1 | $29 |
| Boehringer Ingelheim | 1 | $28 |
| Scilex Pharmaceuticals Inc. | 1 | $25 |
| Grifols USA, LLC | 1 | $20 |
| Merck | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,234 in reported general payments places this provider in the 85th percentile of 6,779 nurse practitioner providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 19 | $16,856 |
| OzempicSemaglutide | 15 | $14,352 |
| Icosapent Ethyl | 14 | $5,225 |
| Pitavastatin Calcium | 15 | $4,232 |
| SynthroidLevothyroxine Sodium | 12 | $1,205 |
| Rosuvastatin Calcium | 45 | $843 |
| Np ThyroidThyroid,pork | 11 | $788 |
| Nebivolol Hcl | 18 | $785 |
| Azelastine Hcl | 22 | $438 |
| Metformin Hcl | 36 | $388 |
| Valsartan | 11 | $381 |
| Pantoprazole Sodium | 21 | $369 |
| Atorvastatin Calcium | 47 | $365 |
| Losartan Potassium | 19 | $358 |
| Levothyroxine Sodium | 44 | $334 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $130 | $16,85619 claims |
| Novo NordiskOzempic | $84 | $14,35215 claims |
| AbbVieSynthroid | $364 | $1,20512 claims |
| Almatica Pharma LLCSertraline Hcl | $51 | $15118 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 6,779 nurse practitioner providers in California.
Other nurse practitioner in Irvine
- Linda TrinhIrvine$899K
- Thu Michelle TranIrvine$33K
- Rhonda HewittStanford$917K
- Denise SinagaNorthridge$728K
- Debbie TaySanta Monica$642K
- Joe GorelickCampbell$638K
- Lynsey LakinArcadia$540K
- Kelly ChoiRancho Cucamonga$483K
- Hamta ZareStanford$428K
- Shawna ChrismanRoseville$425K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.